Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Irinotecan hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for irinotecan hydrochloride and what is the scope of irinotecan hydrochloride patent protection?

Irinotecan hydrochloride
is the generic ingredient in three branded drugs marketed by Teva Pharms Usa, Sun Pharma Global, Hospira, Hisun Pharm Hangzhou, Cipla Ltd, Pliva Lachema, Akorn, Hikma Farmaceutica, Sandoz Inc, Dr Reddys Labs Ltd, West-ward Pharms Int, Accord Hlthcare, Pfizer Inc, Emcure Pharms Ltd, Jiangsu Hengrui Med, Fresenius Kabi Usa, Qilu Pharm Co Ltd, Fresenius Kabi Oncol, Actavis Totowa, Ipsen Inc, Mustafa Nevzat Ilac, and Sandoz, and is included in twenty-three NDAs. There are eleven patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Irinotecan hydrochloride has forty-six patent family members in fifteen countries.

There are thirty-two drug master file entries for irinotecan hydrochloride. Thirteen suppliers are listed for this compound.

Summary for Generic Name: irinotecan hydrochloride

Drug Master File Entries: see list32
Suppliers / Packagers: see list13
Bulk Api Vendors: see list48
Clinical Trials: see list1,319
Patent Applications: see list4,803
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:irinotecan hydrochloride at DailyMed

Pharmacology for Ingredient: irinotecan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ipsen Inc
irinotecan hydrochloride
INJECTABLE, LIPOSOMAL;IV (INFUSION)207793-001Oct 22, 2015RXYesYes9,364,473► Subscribe ► Subscribe
Ipsen Inc
irinotecan hydrochloride
INJECTABLE, LIPOSOMAL;IV (INFUSION)207793-001Oct 22, 2015RXYesYes9,452,162► Subscribe ► Subscribe
Mustafa Nevzat Ilac
irinotecan hydrochloride
INJECTABLE;INJECTION090393-003May 13, 2011APRXNoNo► Subscribe► Subscribe
Cipla Ltd
irinotecan hydrochloride
INJECTABLE;INJECTION077219-002Feb 20, 2008APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
irinotecan hydrochloride
INJECTABLE;INJECTION077776-001Feb 27, 2008APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus